Hassan, Amany K <br/><br/>
Does the use of atypical antipsychotics as adjunctive therapy in depression result in cost savings? Comparing healthcare costs and utilization between second-line treatment options.  [electronic resource] 

 -  Journal of mental health (Abingdon, England)  Dec 2016 
 - 486-491 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1360-0567 
<br/><br/><label>Standard No.: </label>10.3109/09638237.2015.1078879  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antipsychotic Agents--economics<br/>Cost Savings<br/>Depressive Disorder--drug therapy<br/>Drug Therapy, Combination--economics<br/>Female<br/>Health Expenditures<br/>Humans<br/>Male<br/>Medicaid<br/>Middle Aged<br/>United States<br/>Young Adult